Boudreau Philip P
SEC CIK 1805099 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ABT | Abbott Laboratories | VP | 70.8K | $201.3K | $2.61M | 20 | 2021-10-25 | 2026-09-01 |
Most active insiders at ABT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Ford Robert B | COB AND CEO, Dir | $2.01M | $46.20M |
| 2 | STARKS DANIEL J | Dir | $2.01M | — |
| 3 | Morrone Louis H. | EVP | — | $774.7K |
| 4 | Shroff Eric | SVP | — | $285.0K |
| 5 | Boudreau Philip P | EVP AND CFO | $201.3K | — |
| 6 | Stratton John G | Dir | $173.6K | — |
| 7 | Salvadori Daniel Gesua Sive | EVP AND GROUP Pres | — | $102.3K |
| 8 | Moreland Mary K | EVP | — | $70.9K |
| 9 | MCCOY JOHN A. JR. | VP AND Ctrl | — | $70.6K |
| 10 | Cushman Elizabeth C. | EVP, GC AND Sec | — | $30.4K |
Transactions 20
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-03 18:02 | 2026-09-01 | ABT | Abbott Laboratories | Boudreau Philip P | EVP AND CFO | F - Tax | $110.36 | -388 | 70.8K | -0.5% | -$42.8K | |
| I | 2026-04-27 17:34 | 2026-04-23 | ABT | Abbott Laboratories | Boudreau Philip P | EVP AND CFO | I - Discretionary | $92.04 | +8,909 | 9,276 | +2,428% | +$820.0K |
| I | 2026-04-27 17:34 | 2026-04-23 | ABT | Abbott Laboratories | Boudreau Philip P | EVP AND CFO | P - Purchase | $91.50 | +2,200 | 2,200 | New | +$201.3K |
| 2026-03-03 | 2026-02-27 | ABT | Abbott Laboratories | Boudreau Philip P | EVP AND CFO | F - Tax | $116.26 | -7,441 | 71.2K | -9% | -$865.1K | |
| D | 2026-02-26 | 2026-02-24 | ABT | Abbott Laboratories | Boudreau Philip P | EVP AND CFO | A - Grant | $0.00 | +28.0K | 78.6K | +55% | $0 |
| 2025-09-03 | 2025-09-01 | ABT | Abbott Laboratories | Boudreau Philip P | EVP AND CFO | F - Tax | $132.66 | -387 | 50.6K | -0.8% | -$51.3K | |
| 2025-08-11 | 2025-08-08 | ABT | Abbott Laboratories | Boudreau Philip P | EVP AND CFO | S - Sale | $134.55 | -5,550 | 51.0K | -10% | -$746.8K | |
| 2025-03-04 | 2025-02-28 | ABT | Abbott Laboratories | Boudreau Philip P | EVP AND CFO | F - Tax | $135.87 | -4,908 | 56.6K | -8% | -$666.8K | |
| D | 2025-02-27 | 2025-02-25 | ABT | Abbott Laboratories | Boudreau Philip P | EVP | A - Grant | $0.00 | +22.5K | 61.5K | +58% | $0 |
| 2024-09-04 | 2024-09-01 | ABT | Abbott Laboratories | Boudreau Philip P | EVP | F - Tax | $113.27 | -387 | 39.0K | -1.0% | -$43.8K | |
| 2024-03-04 | 2024-02-29 | ABT | Abbott Laboratories | Boudreau Philip P | SVP | F - Tax | $120.05 | -1,738 | 39.4K | -4% | -$208.6K | |
| D | 2024-02-23 | 2024-02-21 | ABT | Abbott Laboratories | Boudreau Philip P | SVP | A - Grant | $0.00 | +23.0K | 41.1K | +127% | $0 |
| D | 2023-09-06 | 2023-09-01 | ABT | Abbott Laboratories | Boudreau Philip P | SVP | A - Grant | $0.00 | +2,620 | 18.1K | +17% | $0 |
| 2023-06-20 | 2023-06-16 | ABT | Abbott Laboratories | Boudreau Philip P | VP | S - Sale | $106.00 | -8,000 | 15.4K | -34% | -$848.0K | |
| 2023-03-02 | 2023-02-28 | ABT | Abbott Laboratories | Boudreau Philip P | VP | F - Tax | $99.77 | -1,477 | 23.4K | -6% | -$147.4K | |
| D | 2023-02-22 | 2023-02-17 | ABT | Abbott Laboratories | Boudreau Philip P | VP | A - Grant | $0.00 | +4,855 | 24.9K | +24% | $0 |
| 2022-03-02 | 2022-02-28 | ABT | Abbott Laboratories | Boudreau Philip P | VP | F - Tax | $122.41 | -1,192 | 20.1K | -6% | -$145.9K | |
| D | 2022-02-23 | 2022-02-18 | ABT | Abbott Laboratories | Boudreau Philip P | VP | A - Grant | $0.00 | +5,351 | 22.2K | +32% | $0 |
| D | 2022-02-23 | 2022-02-22 | ABT | Abbott Laboratories | Boudreau Philip P | VP | F - Tax | $116.79 | -966 | 21.3K | -4% | -$112.8K |
| 2021-10-27 | 2021-10-25 | ABT | Abbott Laboratories | Boudreau Philip P | VP | S - Sale | $126.49 | -8,000 | 16.9K | -32% | -$1.01M |
Purchase Sale Sale after option exercise All abbreviations